Zobrazeno 91 - 100
of 284
pro vyhledávání: '"Daniel Böhringer"'
Autor:
Diana Engesser, Lisa Atzrodt, Thomas Reinhard, Julia Stifter, Daniel Böhringer, Raphael Engesser
Publikováno v:
Klinische Monatsblätter für Augenheilkunde. 236:907-910
Zusammenfassung Hintergrund Viele Sehbehinderte und Blinde können mit vergrößernden Sehhilfen wieder Lesefähigkeit erreichen. Diese Hilfsmittel werden an der Klinik für Augenheilkunde in Freiburg in der Sehbehindertenambulanz im Rahmen einer zei
Autor:
Thabo Lapp, Philip Maier, Philipp Eberwein, Sonja Heinzelmann, Daniel Böhringer, Thomas Reinhard, Christian Haverkamp
Publikováno v:
Cornea. 37:1347-1350
PURPOSE Descemet membrane endothelial keratoplasty (DMEK) seems to be the most promising technique for treating endothelium-related disorders of the cornea. However, graft detachment is a frequent complication. It often can be treated by rebubbling p
Publikováno v:
Der Ophthalmologe
The coronavirus disease 2019 (COVID-19) pandemic restricted face-to-face interactions of medical students and teachers.To develop and evaluate an online course for ophthalmology examination techniques for medical students and to determine the impact
Autor:
Daniel B, Zander, Daniel, Böhringer, Marianne, Fritz, Viviane, Grewing, Philip C, Maier, Thabo, Lapp, Thomas, Reinhard, Katrin, Wacker
Publikováno v:
Ophthalmology. 128(11)
The Eye Drops for Early Morning-Associated Swelling (EDEMAS) trial assessed the efficacy of hyperosmolar eye drops on corneal edema resolution.Double-masked, randomized controlled trial of hyperosmolar eye drops.Participants with Fuchs' dystrophy sch
Autor:
Osama Al-Sheikh, Sultan Al-Zaaidi, Herbert A. Reitsamer, Oliver Stachs, Ebru Toker, Jose M. Benitez-del-Castillo, Christophe Baudouin, Stefano Barabino, Gysbert-Botho van Setten, Jutta Horwath-Winter, R. Beck, Daniel Böhringer, Wolfgang G.K. Müller-Lierheim, Berthold Seitz
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3536, p 3536 (2020)
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3536, p 3536 (2020)
The aim of the HYLAN M study was to investigate if symptoms and/or signs of patients suffering from severe dry eye disease (DED) can be improved by substituting individually optimized artificial tear therapy by high molecular weight hyaluronan (HMWHA
Publikováno v:
International Ophthalmology
Purpose Based on findings of the Asian low-concentration atropine for myopia progression study, a concentration of 0.05% has been proposed as a good compromise between safety and efficacy for myopia control. However, no data on side effects have been
Autor:
Lisa Atzrodt, Martin Wuermeling, Daniel Böhringer, Paola Kammrath Betancor, Helena Wagner, Markus Faessler, Thomas Reinhard, Diana Engesser, Julia Stifter
Publikováno v:
Klinische Monatsblatter fur Augenheilkunde. 237(11)
The demographic change in Germany will lead to an increase in irreversible age-related eye diseases. This will increase the need for specialised care facilities for visually impaired people. Due to reduced mobility, residents in such facilities often
Autor:
Tim, Bleul, Xinyu, Zhuang, Antonia, Hildebrand, Clemens, Lange, Daniel, Böhringer, Günther, Schlunck, Thomas, Reinhard, Thabo, Lapp
Publikováno v:
Journal of Innate Immunity, Pp 1-11 (2020)
J Innate Immun
J Innate Immun
Purpose: To investigate immunological differences and the role of CD38+/F4/80 + M1 macrophages in C57BL/6J- and BALB/c-recipient mouse corneal transplantation models. Methods: Allogeneic transplantation was performed crosswise in BALB/c mice and C57B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a42ffbcf32432c45a9b952d3c6480085
https://www.karger.com/Article/FullText/509716
https://www.karger.com/Article/FullText/509716
Autor:
Thomas Wecker, Bastian Grundel, Milena Grundel, Marie-Christine Bründer, Simon Trick, Clemens Lange, Daniel Böhringer, Hansjürgen Agostini, Andreas Stahl
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Macular edema (ME) is the most frequent vision threatening consequence after retinal vein occlusion (RVO). In this study, we evaluate the effect of dexamethasone intravitreal implants (DII, Ozurdex) in a real-life cohort of 99 patients with ME due to
Autor:
Bastian, Grundel, Marc-Antoine, Bernardeau, Holger, Langner, Christoph, Schmidt, Daniel, Böhringer, Marc, Ritter, Paul, Rosenthal, Andrea, Grandjean, Stefan, Schulz, Philipp, Daumke, Andreas, Stahl
Publikováno v:
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen GesellschaftLiteratur. 118(3)
Anti-VEGF drugs are currently used to treat macular diseases. This has led to a wealth of additional data, which could help understand and predict treatment courses; however, this information is usually only available in free text form.A retrospectiv